Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug ...

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

The foundations of psychedelic capitalism were largely created by public innovation at the public’s expense and are now in ...

A massive industrial development in Montreal‘s East End is aiming to make its mark by becoming North America’s largest ... their first major tenant, pharmaceutical distributor McKesson Canada ...

The tariff war the U.S. is waging against most of the world stabilized somewhat earlier this month. But let's face facts -- ...

Since President Donald J. Trump took office a second time on Jan. 20, leaders across the biotechnology and pharmaceutical ...

U.S. President Donald Trump's trade negotiators are pushing the EU to make unilateral tariff reductions on U.S. goods, saying ...

The "Clinical Documentation Integrity in North America, 2025: Frost Radar Report" report has been added to ResearchAndMarkets.com's offering. As the healthcare industry shifts from a fee-for ...

The U.S. Department of Health and Human Services said on Tuesday it would set drug prices pegged to the lowest level paid by ...

NORWOOD, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced the appointment of ...